RxDoctor Payments Data

Peter Klucar

Family Medicine · Shreveport, LANPI 1104322833

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 135 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,216, more than ten times the $54 reported in 2021.

$2,303in general payments, 2019–2025

Across 135 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$355
  • AstraZeneca$291
  • Amgen$160
  • Pfizer$154
  • Boehringer Ingelheim$154
  • Lilly USA, LLC$149
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$2,303100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,303 in reported general payments places this provider in the 70th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana →

Other family medicine in Shreveport

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →